Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning

Bone

Volumn 36, Issue 5, 2005, Pages 793-802

  Yu, X ^a   Chen, S ^a   Potter, O L ^a   Murthy, S M ^a   Li, J ^a   Pulcini, J M ^a   Ohashi, N ^c   Winata, T ^a   Everett, E T ^b   Ingram, D ^a   Clapp, W D ^a   Hock, J M ^a,b,d  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^c NIIGATA UNIVERSITY   (Japan)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetically modified mice; Neurofibromatosis type I; Osteopontin; Osteoprogenitor; Ras

Indexed keywords

ALKALINE PHOSPHATASE; NEUROFIBROMIN; OSTEOPONTIN; RAS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MASS; BONE STRUCTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; GENE FUNCTION; HETEROZYGOSITY; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; MALE; MARKER GENE; METAPHYSIS; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 20944447547     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.01.022     Document Type: Article

References (40)

1. M. Alvarez, H. Long, J. Onyia, J. Hock, W. Xu, and J. Bidwell Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter Endocrinology 138 1997 482 489
2. R. Atit, M. Crowe, D. Greenhalgh, R. Wenstrup, and N. Ratner The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts J. Invest. Dermatol. 112 1999 835 842
3. S. Boero, M. Catagni, O. Donzelli, R. Facchini, and P. Frediana Congenital pseudoarthrosis of the tibia associated with neurofibromatosis-1: treatment with Ilizarov's device J. Pediatr. Orthop. 17 1997 675 684
4. G. Bollag, D. Clapp, S. Shih, F. Adler, Y. Zhang, and P. Thompson Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in hematopoietic cells Nat. Genet. 12 1996 144 148
5. E. Canalis, J. Pash, and S. Varghese Skeletal growth factors Crit. Rev. Eukaryot. Gene Expr. 3 1993 155 166
6. K. Cichowski, T.S. Shih, E. Schmitt, S. Santiago, K. Reilly, and M. McLaughlin Mouse models of tumor development in neurofibromatosis type 1 Science 286 1999 2171 2176
7. M. Clementi, S. Milani, I. Mammi, S. Boni, C. Monciotti, and R. Tenconi Neurofibromatosis type 1 growth charts Am. J. Med. Genet. 87 1999 317 323
8. A. Crawford, and E. Schorry Neurofibromatosis in children: the role of the orthopedist J. Am. Acad. Orthop. Surg. 7 1999 217 230
9. C. Gennes, D. Kuntz, and M. Vernejoul Bone mastocytosis. A report of 9 cases with a bone histomorphometric study Clin. Orthop. Relat. Res. 279 1992 281 291
10. A. Gilbert, and R. Brockman Congenital pseudarthrosis of the tibia Clin. Orthop. 314 1995 37 44
11. H. Gille, and J. Downward Multiple ras effector pathways contribute to G(1) cell cycle progression J. Biol. Chem. 274 1999 22033 22040
12. X. Guo, Y. Zhang, D. Mitchell, D. Denhardt, and A. Chambers Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell Mol. Cell. Biol. 15 1995 476 487
13. D. Gutmann Learning disabilities in neurofibromatosis 1: sizing up the brain Arch. Neurol. 56 1999 1322 1323
14. D. Gutmann, Y.L. Wu, N.M. Hedrick, Y. Zhu, A. Guha, and L.F. Parada Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes Hum. Mol. Genet. 10 2001 3009 3016
15. D. Ingram, K. Hiatt, A.J. King, L. Fisher, R. Shivakumar, and C. Derstine Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro J. Exp. Med. 194 2001 57 69
16. C. Johansson, G. Roupe, G. Lindstedt, and D. Mellstrom Bone density, bone markers and bone radiological features in mastocytosis Age Ageing 25 1996 1 7
17. T. Kuprilehto, M. Nissinen, J. Koivunen, M. Benson, and J. Peltonen NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos J. Bone Miner. Res. 19 2004 983 989
18. M. Lakkis, and J. Epstein Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart Development 125 1998 4359 4367
19. C. Lidor, B. Frisch, D. Gazit, R. Gepstein, T. Hallel, and Y.A. Mekori Osteoporosis as the sole presentation of bone marrow mastocytosis J. Bone Miner. Res. 5 1990 871 876
20. S. Luckman, D. Hughes, F. Coxon, R. Graham, G. Russell, and M. Rogers Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras J. Bone Miner. Res. 13 1998 581 589
21. F. McCormick Ras signaling and NF1 Curr. Opin. Genet. Dev. 5 1995 51 55
22. M. McKee, M.J. Glimcher, and A. Nanci High-resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia Anat. Rec. 234 1992 479 492
23. M.D. McKee, and A. Nanci Osteopontin and the bone remodeling sequence. Colloidal-gold immunocytochemistry of an interfacial extracellular matrix protein Ann. N. Y. Acad. Sci. 760 1995 177 189
24. E. Mohler, F. Gannon, C. Reynolds, R. Zimmerman, M. Keane, and F. Kaplan Bone formation and inflammation in cardiac valves Circulation 103 2001 1522 1528
25. K. Nose, M. Itami, M. Satake, Y. Ito, and T. Kuroki Abolishment of c-fos inducibility in ras-transformed mouse osteoblast cell lines Mol. Carcinog. 2 1989 208 216
26. J. Onyia, B. Miller, J. Hulman, J. Liang, R. Galvin, and C. Frolik Proliferating cells in the primary spongiosa express the osteoblast phenotype in vitro Bone 20 1997 93 100
27. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, and P.J. Meunier Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee J. Bone Miner. Res. 2 1987 595 610
28. M. Poyhonen, J. Heikkinen, K. Vaananen, and J. Peltonen Osteoporosis in neurofibromatosis type 1 Am. Soc Hum. Genet. Ann. Mtg. 2000 [ http:/www.faseb.org/genetics/ashg00/f631.htm ]
29. V. Riccardi Neurofibromatosis: Phenotype, Natural History and Pathogenesis 1992 The Johns Hopkins University Press Baltimore, MD 479
30. V. Riccardi, J.E. Womack, and T. Jacks Neurofibromatosis and related tumors. Natural occurrence and animal models Am. J. Pathol. 145 1994 994 1000
31. L. Sherman, T. Rizvi, S. Karyala, and N. Ratner CD44 enhances neuroregulin signaling by Schwann cells J. Cell Biol. 150 2000 1071 1084
32. L.S. Sherman, R. Atit, T. Rosenbaum, A.D. Cox, and N. Ratner Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts J. Biol. Chem. 275 2000 30740 30745
33. D. Stanislaus, X. Yang, J. Liang, J. Wolfe, R. Cain, and J. Onyia In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone, hPTH 1-34 fragment Bone 27 2000 209 218
34. Y. Tanaka, S. Nakayamada, H. Fujimoto, Y. Okada, H. Umehara, and T. Kataoka H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts J. Biol. Chem. 277 2002 21446 21452
35. R. Virdis, M.E. Street, M.A. Bandello, C. Tripodi, A. Donadio, and A.R. Villani Growth and pubertal disorders in neurofibromatosis type 1 J. Pediatr. Endocrinol. Metab. 16 Suppl. 2 2003 289 292
36. M. Vitale, A. Guha, and D. Skaggs Orthopedic manifestations of neurofibromatosis in children: an update Clin. Orthop. Relat. Res. 1 2002 107 118
37. F. Wang, C. Wang, H. Huang, H. Chung, R. Chen, and K. Yang Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells Biochem. Biophys. Res. Commun. 287 2001 648 655
38. M. Yamazaki, F. Nakajima, A. Ogasawara, H. Moriya, R.J. Majeska, and T.A. Einhorn Spatial and temporal distribution of CD44 and osteopontin in fracture callus J. Bone Joint Surg. Br. 81 1999 508 515
39. J. You, G.C. Reilly, X. Zhen, C.E. Yellowley, Q. Chen, and H. Donahue Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts J. Biol. Chem. 276 2001 13365 13371
40. Y. Zhu, P. Ghosh, P. Charnay, D. Burns, and L. Parada Neurofibromas in NF1: Schwann cell origin and role of tumor environment Science 296 2002 920 922